NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000005191

Registered date:06/03/2011

XELOX stop-and-go trial:A phase 2 study of 1st line chemotherapy for unresectable or recurrent colorectal cancer.

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedUnresectable or recurrent colorectal cancer
Date of first enrollment2010/05/01
Target sample size37
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)XELOX therapy 6 courses, followed by XELODA 6 courses, then XELOX

Outcome(s)

Primary OutcomeProgression free survival
Secondary OutcomeResponse rate Time to treatment failure Overall survival Safety plofiles(Rate of Grade 3 neurotoxicity, adverse events)

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum75years-old
GenderMale and Female
Include criteria
Exclude criteriaDouble cancer, severe allergic history, active infections, severe complications

Related Information

Contact

public contact
Name
Address Japan
Telephone
E-mail
Affiliation Kyushu University Hospital Hematology and Oncology
scientific contact
Name Eishi Baba
Address 3-1-1, Maedashi, Higashi-ku, Fukuokashi Japan
Telephone
E-mail
Affiliation Kyushu University Hospital Hematology and Oncology